Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
19.45    -0.65 (-3.23%)
Bid:
19.00
Ask:
19.90
Spread: 0.90 (4.737%)
Market Cap: €111.86b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

BBVA offer modification

9 Jan 2025 17:48

RNS Number : 8202S
Banco Bilbao Vizcaya Argentaria SA
09 January 2025
 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA"), in accordance with the provisions of the Securities Market legislation, hereby communicates, at the request of the Spanish Securities Market Commission (CNMV) and in accordance with the provisions of Article 234 of Law 6/2023, of March 17, on Securities Markets and Investment Services, the following:

 

INSIDE INFORMATION

 

In relation to the voluntary tender offer launched by BBVA for the entire share capital of Banco de Sabadell, S.A. ("Banco Sabadell" or the "Target Company") (the "Offer"), for which the prior announcement was published as inside information on May 9, 2024 and the request for authorisation was submitted to the CNMV on May 24, 2024 and gave leave to proceed on June 11, 2024, BBVA informs that it has decided to modify the Offer by reducing the minimum acceptance condition provided in the prior announcement, which implies a more favorable treatment for its recipients, in accordance with Article 31.1 of Royal Decree 1066/2007.

The aforementioned minimum acceptance condition, which initially required the acceptance of the Offer by at least 2,720,654,746 shares of the Target Company, representing 50.01 percent of its share capital, is now reduced so that it requires the Offer to be accepted for a number of shares that allows BBVA to acquire at least more than half of the effective voting rights of Banco Sabadell at the end of the Offer acceptance period (therefore excluding the treasury shares that the Target Company may hold at that time).

As of the date of this communication, the total share capital with voting rights amounts to 5,361,450,912 ordinary shares (5,361,450 effective voting rights), considering that Banco Sabadell's share capital is represented by a total of 5,440,221,447 ordinary shares (5,440,221 voting rights) and that it holds 78,770,535 treasury shares (as stated in Banco Sabadell's Universal Registration Document posted on the CNMV's website on May 23, 2024), whose voting rights are suspended in accordance with Article 148(a) of the Spanish Companies Act. Therefore, assuming that all such treasury shares remain as such at the end of the Offer acceptance period, the reduced minimum acceptance condition will be deemed fulfilled if the Offer is accepted for at least 2,680,726,000 shares of Banco Sabadell (2,680,726 voting rights), which would represent half plus one of Banco Sabadell's effective voting rights at that time.

The above notwithstanding, if Banco Sabadell's treasury shares vary by the end of the acceptance period, the condition will be deemed fulfilled if the Offer is accepted for the number of shares necessary to acquire more than 50 percent of the effective voting rights at that time, thus excluding the suspended voting rights corresponding to the treasury shares held by Banco Sabadell on that date.

In the event of a positive outcome of the Offer, BBVA will seek the redemption of Banco Sabadell's treasury shares at the end of the acceptance period at the first General Shareholders' Meeting of Banco Sabadell, reducing the share capital and locking up those shares in the meantime. 

The fulfillment of this reduced minimum acceptance condition, under the described terms, will make applicable the exception to the obligation to launch a mandatory tender offer in accordance with Article 8(f) of Royal Decree 1066/2007, to the extent that the Offer would have been accepted for shares representing, at least, 50 percent of the effective voting rights to which it was addressed.

BBVA will submit to the CNMV the documentation related to the improved terms of the Offer in accordance with Articles 17 and 20 of Royal Decree 1066/2007.

 

 

Madrid, January 9, 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSIFWUEISELF
Date   Source Headline
1st Jun 202610:20 amRNSPeriodic Report on the Buyback Program 01/06/2026
26th May 20267:00 amRNSPeriodic Report on the Buyback Program 25/05/2026
18th May 202610:18 amRNSPeriodic Report on the Buyback Program 18/05/2026
12th May 20266:23 pmRNSHR - Fitch rating upgrade
11th May 202610:17 amRNSPeriodic Report on the Buyback Program 11/05/2026
1st May 20267:00 amRNSIssue of preferred sec. contingently convertible
1st May 20267:00 amRNSChanges in BBVA’s Board of Directors
30th Apr 20268:39 amRNSShare Buyback Program
30th Apr 20267:19 amRNS1Q26 Earnings Presentation
30th Apr 20267:16 amRNS1Q26 Quarterly Report
30th Apr 20267:12 amRNSResults Press Release BBVA 1T2026
22nd Apr 20261:24 pmRNS1T26 Earnings Presentation Announcement
20th Apr 20267:00 amRNSCompletion of the execution of the Second Tranche
17th Apr 20267:14 amRNSEarly redemption of public sector covered bonds
15th Apr 20262:57 pmRNSBBVA Notice to amend final terms GMTN 29
14th Apr 20265:20 pmRNSMREL requirement
13th Apr 202610:19 amRNSPeriodic Report on the Buyback Program 13/04/2026
7th Apr 20267:00 amRNSPeriodic Report on the Buyback Program 06/04/2026
31st Mar 20265:50 pmRNSBBVAs share capital reduction
23rd Mar 20267:00 amRNSPilar 3 Report 2025
20th Mar 202611:50 amRNSShare Buyback Program
6th Mar 20266:19 pmRNSCompletion of the execution of the First Tranche
2nd Mar 202610:18 amRNSPeriodic Report on the Buyback Program 2026/03/02
23rd Feb 202610:29 amRNSPeriodic Report on the Buyback Program 23/02/2026
19th Feb 202610:46 amRNS2025_Individual_Annual_Accounts_and_Management_Rep
19th Feb 202610:37 amRNS2025_Cons_Annual_Accounts_and_Management_Report
16th Feb 202610:24 amRNSPeriodic Report on the Buyback Program 2026/02/16
13th Feb 20265:22 pmRNSApril dividend calendar
13th Feb 20263:33 pmRNS2026 AGM Notice and Proposed Resolutions
11th Feb 20265:44 pmRNSEarly redemption of Senior Preferred Notes
10th Feb 20267:00 amRNS2026 Annual General Meeting Call
9th Feb 202610:11 amRNSPeriodic Report on the Buyback Program 2026/02/09
5th Feb 20267:00 amRNSShareholder remuneration for 2025
5th Feb 20267:00 amRNS4Q25 Earnings Report
5th Feb 20267:00 amRNS4Q25 Earnings Press Release
5th Feb 20267:00 amRNS4Q25 Earnings Presentation
2nd Feb 202610:27 amRNSPeriodic Report on the Buyback Program 02/02/2026
28th Jan 20261:29 pmRNS4Q25 Earnings Presentation Announcement
27th Jan 20267:00 amRNSNew Periodic Report Buyback Program 26/01/2026
26th Jan 202610:30 amRNSPeriodic Report on the Buyback Program 26/01/2026
19th Jan 202610:06 amRNSPeriodic Report on the Buyback Program 19/01/2026
12th Jan 202610:18 amRNSPeriodic Report on the Buyback Program 12/01/2026
2nd Jan 202610:39 amRNSPeriodic Report on the Buyback Program 02/01/2026
23rd Dec 20255:28 pmRNSBBVA's share capital reduction
23rd Dec 20255:28 pmRNSBBVA's share capital reduction
19th Dec 20257:21 amRNSShare Buyback Program
19th Dec 20257:21 amRNSShare Buyback Program
17th Dec 20257:47 amRNSEarly redemption of the entire issuance
11th Dec 20257:00 amRNSCompletion of the execution of the Buyback Program
9th Dec 202510:30 amRNSPeriodic Report on the Buyback Program 2025/12/09

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.